About us


Founded in 2014, Neolys is the result of a collaboration between industrialists and radiobiology researchers in Lyon with one purpose: to predict the toxicity reactions after radiotherapy for each patient, taking into account individual specificities. 

Neolys has developed a reliable technology based on the implementation of predictive tests, allowing for personalized therapeutic treatments. Our solutions optimize both the effectiveness of radiotherapy treatments and the prevention of toxicities.

In 2019, Neolys Diagnostics joined Alara Group, a unique group specialized in healthcare risk management, from physical dosimetry to biological and clinical risk assessment with Fibermetrix, ALARA Expertise and Spin Up.


Our values and commitment

We promote fundamental values, characteristic of our commitment and our work: the respect of biomedical ethics, a will to improve patients’ care and quality of life. 

These values are reflected in our actions:

  • Participation in the development of personalized medicine 
  • Treatment optimization
  • Prevention of environmental or medical-related toxicity
  • Continuous improvement of our solutions
  • Innovations to broaden our scope 
Learn more about our solutions

Our Team

Our team is mainly composed of professional biology researchers, specialized in radiobiology. 

A unique know-how

All our team members share a deep knowledge of individual radiosensitivity. 

Sandrine Pereira

Director of R&D

PhD in radiobiology, Sandrine is also an industrial transfer and medical devices specialist. She supervises the R&D department of the company.

Elise Berthel

R&D Project Manager

PhD in radiobiology, Elise supervises the company’s research and development unit.

Mirlande Duclos

Laboratory technician

Mirlande takes part in R&D experiments and is specialized in performing radiosensitivity tests.

Patrick Barhoum

Business Developer

Phd in science specialising in chemistry and biology and a master's degree in innovation management. Patrick is in charge of business development.

Our scientific partners

Follow us
Laboratory form